Sorry, that was ambiguous on my part. There’s a delineation between research ethics issues (how trials are run, etc.) and clinical ethics (medical aid in dying, selling one’s organs, accessing unapproved treatments, etc.). My work focuses on the former, not the latter, so I can’t speak much to that. I meant “conservative” in the sense of hesitance to adjust existing norms or systems in research ethics oversight and, for example, a very strong default orientation towards any measures that reduce risk (or seem to reduce risk) for research participants.
Sorry, that was ambiguous on my part. There’s a delineation between research ethics issues (how trials are run, etc.) and clinical ethics (medical aid in dying, selling one’s organs, accessing unapproved treatments, etc.). My work focuses on the former, not the latter, so I can’t speak much to that. I meant “conservative” in the sense of hesitance to adjust existing norms or systems in research ethics oversight and, for example, a very strong default orientation towards any measures that reduce risk (or seem to reduce risk) for research participants.